-
Je něco špatně v tomto záznamu ?
Allosteric Effect of Adenosine Triphosphate on Peptide Recognition by 3'5'-Cyclic Adenosine Monophosphate Dependent Protein Kinase Catalytic Subunits
R. Kivi, K. Solovjova, T. Haljasorg, P. Arukuusk, J. Järv,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 2004-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2011-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2004-01-01 do Před 1 rokem
- MeSH
- 2-naftylamin analogy a deriváty chemie MeSH
- adenosintrifosfát chemie metabolismus MeSH
- alosterická regulace MeSH
- alosterické místo MeSH
- AMP cyklický chemie metabolismus MeSH
- barvení a značení metody MeSH
- fluorescenční barviva chemie MeSH
- inhibitory proteinkinas chemie metabolismus MeSH
- katalytická doména MeSH
- kinetika MeSH
- lidé MeSH
- ligandy MeSH
- peptidy chemie metabolismus MeSH
- proteinkinasy závislé na cyklickém AMP chemie metabolismus MeSH
- sekvence aminokyselin MeSH
- termodynamika MeSH
- vazba proteinů MeSH
- vazebná místa MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
The allosteric influence of adenosine triphosphate (ATP) on the binding effectiveness of a series of peptide inhibitors with the catalytic subunit of 3'5'-cyclic adenosine monophosphate dependent protein kinase was investigated, and the dependence of this effect on peptide structure was analyzed. The allosteric effect was calculated as ratio of peptide binding effectiveness with the enzyme-ATP complex and with the free enzyme, quantified by the competitive inhibition of the enzyme in the presence of ATP excess, and by the enzyme-peptide complex denaturation assay, respectively It was found that the principle "better binding-stronger allostery" holds for interactions of the studied peptides with the enzyme, indicating that allostery and peptide binding with the free enzyme are governed by the same specificity pattern. This means that the allosteric regulation does not include new ligand-protein interactions, but changes the intensity (strength) of the interatomic forces that govern the complex formation in the case of each individual ligand. We propose that the allosteric regulation can be explained by the alteration of the intrinsic dynamics of the protein by ligand binding, and that this phenomenon, in turn, modulates the ligand off-rate from its binding site as well as the binding affinity. The positive allostery could therefore be induced by a reduction in the enzyme's overall intrinsic dynamics.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023497
- 003
- CZ-PrNML
- 005
- 20170830103837.0
- 007
- ta
- 008
- 170720s2016 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10930-016-9691-9 $2 doi
- 035 __
- $a (PubMed)27848106
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kivi, Rait $u Institute of Chemistry, University of Tartu, Tartu, Estonia. Institute of Technology, University of Tartu, Tartu, Estonia.
- 245 10
- $a Allosteric Effect of Adenosine Triphosphate on Peptide Recognition by 3'5'-Cyclic Adenosine Monophosphate Dependent Protein Kinase Catalytic Subunits / $c R. Kivi, K. Solovjova, T. Haljasorg, P. Arukuusk, J. Järv,
- 520 9_
- $a The allosteric influence of adenosine triphosphate (ATP) on the binding effectiveness of a series of peptide inhibitors with the catalytic subunit of 3'5'-cyclic adenosine monophosphate dependent protein kinase was investigated, and the dependence of this effect on peptide structure was analyzed. The allosteric effect was calculated as ratio of peptide binding effectiveness with the enzyme-ATP complex and with the free enzyme, quantified by the competitive inhibition of the enzyme in the presence of ATP excess, and by the enzyme-peptide complex denaturation assay, respectively It was found that the principle "better binding-stronger allostery" holds for interactions of the studied peptides with the enzyme, indicating that allostery and peptide binding with the free enzyme are governed by the same specificity pattern. This means that the allosteric regulation does not include new ligand-protein interactions, but changes the intensity (strength) of the interatomic forces that govern the complex formation in the case of each individual ligand. We propose that the allosteric regulation can be explained by the alteration of the intrinsic dynamics of the protein by ligand binding, and that this phenomenon, in turn, modulates the ligand off-rate from its binding site as well as the binding affinity. The positive allostery could therefore be induced by a reduction in the enzyme's overall intrinsic dynamics.
- 650 _2
- $a 2-naftylamin $x analogy a deriváty $x chemie $7 D015081
- 650 _2
- $a adenosintrifosfát $x chemie $x metabolismus $7 D000255
- 650 _2
- $a alosterická regulace $7 D000494
- 650 _2
- $a alosterické místo $7 D000495
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a AMP cyklický $x chemie $x metabolismus $7 D000242
- 650 _2
- $a proteinkinasy závislé na cyklickém AMP $x chemie $x metabolismus $7 D017868
- 650 _2
- $a fluorescenční barviva $x chemie $7 D005456
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a peptidy $x chemie $x metabolismus $7 D010455
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a inhibitory proteinkinas $x chemie $x metabolismus $7 D047428
- 650 _2
- $a barvení a značení $x metody $7 D013194
- 650 _2
- $a termodynamika $7 D013816
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Solovjova, Karina $u Institute of Chemistry, University of Tartu, Tartu, Estonia. CEITEC - Central European Institute of Technology, Masaryk University, Kamenice 753/5, 625 00, Brno, Czech Republic.
- 700 1_
- $a Haljasorg, Tõiv $u Institute of Chemistry, University of Tartu, Tartu, Estonia.
- 700 1_
- $a Arukuusk, Piret $u Institute of Technology, University of Tartu, Tartu, Estonia. $7 gn_A_00009063
- 700 1_
- $a Järv, Jaak $u Institute of Chemistry, University of Tartu, Tartu, Estonia. jaak.jarv@ut.ee.
- 773 0_
- $w MED00149895 $t The protein journal $x 1875-8355 $g Roč. 35, č. 6 (2016), s. 459-466
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27848106 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170830104426 $b ABA008
- 999 __
- $a ok $b bmc $g 1239178 $s 984410
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 35 $c 6 $d 459-466 $i 1875-8355 $m The protein journal $n Protein J $x MED00149895
- LZP __
- $a Pubmed-20170720